gadolinium has been researched along with Melanoma, Amelanotic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Furumoto, H; Matsuzaki, K; Nishitani, H; Takeuchi, M; Uehara, H | 1 |
| Kramann, B; Schneider, G; Seidel, R; Uder, M; Wagner, D; Weinmann, HJ | 1 |
2 other study(ies) available for gadolinium and Melanoma, Amelanotic
| Article | Year |
|---|---|
A case of metastatic malignant melanoma of the ovary with a multilocular cystic appearance on MR imaging.
Topics: Adult; Ascites; Diagnosis, Differential; Fatal Outcome; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Melanoma; Melanoma, Amelanotic; Ovarian Cysts; Ovarian Neoplasms; Skin Neoplasms; Time Factors; Treatment Outcome | 2009 |
In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Topics: Animals; Capillary Permeability; Contrast Media; Cricetinae; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Melanoma, Experimental; Microcirculation; Microscopy, Fluorescence; Organometallic Compounds; Random Allocation; Skin Neoplasms; Time Factors; Video Recording | 2000 |